Drug intelligence / Profile preview

Baoji

Development stage: Unknown
Lead developer: West China Hospital of Sichuan University
Administration: Oral

Overview

Baoji is a Traditional Chinese Medicine (TCM) formulation, commonly available as pills (Baoji Wan) or tablets, used primarily for the treatment of gastrointestinal disorders and the prevention of motion sickness. In the context of TCM, it is indicated for "turbid dampness stagnation syndrome," which manifests as nausea, vomiting, abdominal pain, and diarrhea. The formulation typically contains a complex blend of herbal ingredients, including Poria, Radix Aucklandiae, and Herba Pogostemonis, which work synergistically to regulate the digestive system and alleviate symptoms of dampness. A multicenter clinical trial sponsored by West China Hospital of Sichuan University has investigated its efficacy and safety specifically for motion sickness.

Brand names: Baoji TabletsPo Chai Pills
Other names: Baoji WanBao Ji Wan

Beyond the preview

Go deeper on Baoji.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baoji.

Explore the full profile